These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22350031)

  • 1. Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy.
    Santulli G; D'Ascia C
    Heart; 2012 Mar; 98(6):517; author reply 517. PubMed ID: 22350031
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
    Steffel J; Milosevic G; Hürlimann A; Krasniqi N; Namdar M; Ruschitzka F; Lüscher TF; Duru F; Holzmeister J; Hürlimann D
    Heart; 2011 Oct; 97(20):1668-74. PubMed ID: 21821856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of cardiac resynchronization therapy in the recovery of patients with left ventricular assist devices.
    Verreault-Julien L; Philippon F; Charbonneau É; Kalavrouziotis D; LeRoux É; Sarrazin JF; Dubois M; Voisine P; Sénéchal M
    Int J Cardiol; 2016 Nov; 223():297-298. PubMed ID: 27541678
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac resynchronization therapy: Twelve-month effects of echocardiographic atrio-ventricular and inter-ventricular delay optimization. Rationale and design of the CARTEDO trial.
    Donazzan L; Rigolli M; De Simone V; Bergamini C; Tomasi L; Zanolla L; Vassanelli C
    Int J Cardiol; 2016 Jan; 202():185-7. PubMed ID: 26397407
    [No Abstract]   [Full Text] [Related]  

  • 5. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy reduces left ventricular energy loss.
    Kakizaki R; Nabeta T; Ishii S; Koitabashi T; Itatani K; Inomata T; Ako J
    Int J Cardiol; 2016 Oct; 221():546-8. PubMed ID: 27414737
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Echocardiographic Response to Cardiac Resynchronization Therapy in Initial Nonresponders.
    Burns KV; Gage RM; Curtin AE; Bank AJ
    JACC Heart Fail; 2015 Dec; 3(12):990-7. PubMed ID: 26577619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gated SPECT left ventricular shape and prediction of super responders to cardiac resynchronization therapy: Not so easy as it (LV) looks.
    Altawil M; Greenberg J; Ananthasubramaniam K
    J Nucl Cardiol; 2022 Aug; 29(4):1547-1551. PubMed ID: 33608854
    [No Abstract]   [Full Text] [Related]  

  • 12. Newer Echocardiographic Techniques in Cardiac Resynchronization Therapy.
    Gorcsan J; Tayal B
    Heart Fail Clin; 2017 Jan; 13(1):53-62. PubMed ID: 27886932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy.
    Pappone C; Ćalović Ž; Vicedomini G; Cuko A; McSpadden LC; Ryu K; Romano E; Baldi M; Saviano M; Pappone A; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Vitale R; Fundaliotis A; Tavazzi L; Santinelli V
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):58-63. PubMed ID: 25109276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.
    Fröhlich G; Steffel J; Hürlimann D; Enseleit F; Lüscher TF; Ruschitzka F; Abraham WT; Holzmeister J
    Eur Heart J; 2010 Jun; 31(12):1477-85. PubMed ID: 20233792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiac resynchronization therapy on left ventricular mechanical dyssynchrony induced by right ventricular pacing in a patient with heart failure and preserved ejection fraction.
    Takeuchi T; Dohi K; Kumagai N; Nakamori S; Fujimoto N; Okamoto R; Fujii E; Kitamura T; Yamada N; Nakamura M; Hamada M; Ito M
    Int J Cardiol; 2014 Dec; 177(3):1069-72. PubMed ID: 25466569
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
    Mitro P; Murin P; Valocik G; Simurda M
    Cardiol J; 2014; 21(5):524-31. PubMed ID: 24526506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metric for evaluating the cardiac response to resynchronization therapy.
    Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
    Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT.
    Kutyifa V; Solomon SD; Bourgoun M; Shah AM; Pouleur AC; Knappe D; McNitt S; Wang PJ; Merkely B; Pfeffer M; Moss AJ; Zareba W
    Heart Rhythm; 2013 Mar; 10(3):354-60. PubMed ID: 23174486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.